BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 754784)

  • 1. [The anti-angina action of carnitine].
    Cherchi A; Fonzo R; Lai C; Mercuro G; Corsi M
    Boll Soc Ital Cardiol; 1978; 23(1):71-89. PubMed ID: 754784
    [No Abstract]   [Full Text] [Related]  

  • 2. The qualitative dynamics of angina pectoris and the effect of certain drugs as recorded with the high-frequency (acceleration) direct body ballistocardiograph.
    Winer NJ
    Bibl Cardiol; 1973; 0(31):181-8. PubMed ID: 4213474
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-anginal action, by opposite mechanisms, of nitroglycerin and propranolol].
    Giani P; Folli G; Bruno L; Binaghi G; Rizzato GF; Bandera L
    Cuore Circ; 1969 Oct; 53(5):213-32. PubMed ID: 4984065
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study.
    Cherchi A; Lai C; Angelino F; Trucco G; Caponnetto S; Mereto PE; Rosolen G; Manzoli U; Schiavoni G; Reale A
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):569-72. PubMed ID: 3905631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propionyl-L-carnitine: a new compound in the metabolic approach to the treatment of effort angina.
    Lagioia R; Scrutinio D; Mangini SG; Ricci A; Mastropasqua F; Valentini G; Ramunni G; Totaro Fila G; Rizzon P
    Int J Cardiol; 1992 Feb; 34(2):167-72. PubMed ID: 1737667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Limitations of the angiotensin II test for the recognition of angina pectoris (author's transl)].
    Radice M; Tavecchia A; Mazzoleni D; Folli G
    G Ital Cardiol; 1974; 4(6):703-9. PubMed ID: 4375067
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans.
    Bartels GL; Remme WJ; Pillay M; Schönfeld DH; Cox PH; Kruijssen HA; Knufman NM
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):157-64. PubMed ID: 1383625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of captopril in stable angina pectoris].
    Rodríguez Gilabert C; Antúnez Sánchez J; Miravete Oropeza R
    Arch Inst Cardiol Mex; 1992; 62(3):263-6. PubMed ID: 1632718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological properties of a new anti-anginal agent: amiodarone].
    Moret PR; Boufas D; Fournet PC
    Schweiz Med Wochenschr; 1969 Jul; 99(30):1090-5. PubMed ID: 5351143
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacologic therapy of angina pectoris].
    Siepe O
    Minerva Med; 1972 Apr; 63(31):1800-3. PubMed ID: 4402001
    [No Abstract]   [Full Text] [Related]  

  • 11. Nitroglycerine in angina.
    Br Med J; 1970 Aug; 3(5717):239. PubMed ID: 4988640
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical studies on the action of iproveratril in coronary insufficiency and on the influencing of myocardial function using sympatholytics].
    Hofmann H
    Z Gesamte Inn Med; 1968 Jun; 23(12):357-64. PubMed ID: 4386847
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trial of a new anti-angina drug: Vascoril (67 53 MD)].
    Warembourg H; Bertrand M; Ginestet A
    Lille Med; 1972 May; 17():Suppl 4:804-8. PubMed ID: 5056283
    [No Abstract]   [Full Text] [Related]  

  • 14. [Camazepam (B 5833) in therapy of angina pectoris].
    Grosso F
    Clin Ter; 1974 Oct; 71(1):49-55. PubMed ID: 4214644
    [No Abstract]   [Full Text] [Related]  

  • 15. A double blind drug trial of LB-46 (visken) in angina pectoris.
    Sainani GS; Mukherjee AK
    Indian Heart J; 1972 Jun; 24():Suppl 1:192-6. PubMed ID: 4581427
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of ischemic heart diseases with carbochromen].
    Savenkov PM; Arsukuni RO; Pflug C
    Arzneimittelforschung; 1970 Mar; 20():461-2. PubMed ID: 5468731
    [No Abstract]   [Full Text] [Related]  

  • 17. Myocardial metabolism and anginal threshold in coronary disease after verapamil administration.
    Ferlinz J; Turbow ME; Aronow WS
    Clin Invest Med; 1980; 3(1-2):101-9. PubMed ID: 7471535
    [No Abstract]   [Full Text] [Related]  

  • 18. Different effects of nitroglycerin and nitroprusside on myocardial blood flow and metabolism.
    Ihlen H
    Scand J Clin Lab Invest Suppl; 1984; 173():75-9. PubMed ID: 6442005
    [No Abstract]   [Full Text] [Related]  

  • 19. A double blind study of Visken LB-46, in the treatment of angina pectoris.
    Nair DV
    Indian Heart J; 1972 Jun; 24():Suppl 1:183-91. PubMed ID: 4581426
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sleep pattern and hemodynamic modifications in angina pectoris].
    Maggini C; Guazzelli M; Chierchia S; Cassano GB; Maseri A
    Riv Neurol; 1977; 47(5):507-22. PubMed ID: 201014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.